Wang Cun, Zhang Yurong, Guo Kun, Wang Ning, Jin Haojie, Liu Yinkun, Qin Wenxin
State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Liver Cancer Institute, Zhongshan Hospital and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Fudan University, Shanghai, China.
Int J Cancer. 2016 Apr 15;138(8):1824-34. doi: 10.1002/ijc.29723. Epub 2015 Aug 19.
Heat shock proteins (HSPs) are highly conserved proteins, which are expressed at low levels under normal conditions, but significantly induced in response to cellular stresses. As molecular chaperones, HSPs play crucial roles in protein homeostasis, apoptosis, invasion and cellular signaling transduction. The induction of HSPs is an important part of heat shock response, which could help cancer cells to adapt to stress conditions. Because of the constant stress condition in tumor microenvironment, HSPs overexpression is widely reported in many human cancers. In light of the significance of HSPs for cancer cells to survive and obtain invasive phenotype under stress condition, HSPs are often associated with poor prognosis and treatment resistance in many types of human cancers. It has been described that upregulation of HSPs may serve as diagnostic and prognostic markers in hepatocellular carcinoma (HCC). Targeting HSPs with specific inhibitor alone or in combination with chemotherapy regimens holds promise for the improvement of outcomes for HCC patients. In this review, we summarize the expression profiles, functions and molecular mechanisms of HSPs (HSP27, HSP70 and HSP90) as well as a HSP-like protein (clusterin) in HCC. In addition, we address progression and challenges in targeting these HSPs as novel therapeutic strategies in HCC.
热休克蛋白(HSPs)是高度保守的蛋白质,在正常条件下低水平表达,但在细胞应激时会显著诱导表达。作为分子伴侣,热休克蛋白在蛋白质稳态、细胞凋亡、侵袭和细胞信号转导中发挥关键作用。热休克蛋白的诱导是热休克反应的重要组成部分,这有助于癌细胞适应应激条件。由于肿瘤微环境中存在持续的应激状态,热休克蛋白在许多人类癌症中均有广泛的过表达报道。鉴于热休克蛋白对癌细胞在应激条件下存活和获得侵袭表型的重要性,热休克蛋白在许多类型的人类癌症中常与预后不良和治疗耐药相关。已有研究表明,热休克蛋白的上调可能作为肝细胞癌(HCC)的诊断和预后标志物。单独使用或与化疗方案联合使用针对热休克蛋白的特异性抑制剂有望改善HCC患者的治疗效果。在本综述中,我们总结了热休克蛋白(HSP27、HSP70和HSP90)以及一种类热休克蛋白(簇集素)在HCC中的表达谱、功能和分子机制。此外,我们还探讨了将这些热休克蛋白作为HCC新型治疗策略的研究进展和挑战。